Edwards Lifesciences (EW) Short-Term Debt issuances (2010 - 2013)

Edwards Lifesciences' Short-Term Debt issuances history runs 4 years deep, the most recent figure standing at $372.9 million for Q3 2013.

• In Q3 2013, Short-Term Debt issuances rose 1036.89% year-over-year to $372.9 million; the TTM figure through Sep 2013 stood at $874.2 million (up 238.18% YoY), while the FY2012 annual figure was $407.0 million, down 22.64% from the prior year.
• Short-Term Debt issuances was $372.9 million for Q3 2013 at Edwards Lifesciences, up from $168.4 million in the prior quarter.
• In the past five years, Short-Term Debt issuances ranged from a high of $372.9 million in Q3 2013 to a low of $20.6 million in Q4 2011.
• Historically, Short-Term Debt issuances has averaged $126.2 million across 4 years, with a median of $104.5 million in 2010.
• The sharpest annual moves came in 2012 and 2013: Short-Term Debt issuances plunged 89.25% in 2012, then surged 1036.89% in 2013.
• A 4-year view of Short-Term Debt issuances shows it stood at $37.6 million in 2010, then sank by 45.21% to $20.6 million in 2011, then surged by 720.87% to $169.1 million in 2012, then soared by 120.52% to $372.9 million in 2013.
• The last three Short-Term Debt issuances figures came in at $372.9 million (Q3 2013), $168.4 million (Q2 2013), and $163.8 million (Q1 2013), per Business Quant data.